PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.\', \'Department of Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel. roits@clalit.org.il.\', \'Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel.\', \'Neuro-Oncology Unit, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.\', \'Faculty of Medicine, Hebrew University, Jerusalem, Israel.\', \'Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.\', \'Infectious Disease Unit, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11060-021-03911-7
?:hasPublicationType
?:journal
  • Journal of neuro-oncology
is ?:pmid of
?:pmid
?:pmid
  • 35018613
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.168
?:rankingScore_hIndex
  • 102
?:title
  • Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35018613>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35018613>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all